Geode Capital Management LLC Grows Position in Senseonics Holdings, Inc. (NYSE:SENS)

Geode Capital Management LLC lifted its position in shares of Senseonics Holdings, Inc. (NYSE:SENS - Free Report) by 9.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,405,100 shares of the company's stock after buying an additional 566,704 shares during the quarter. Geode Capital Management LLC owned about 1.08% of Senseonics worth $3,354,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the business. Raymond James Financial Inc. acquired a new position in Senseonics during the fourth quarter worth about $26,000. HighTower Advisors LLC bought a new stake in Senseonics in the fourth quarter valued at approximately $32,000. Ridgecrest Wealth Partners LLC bought a new position in shares of Senseonics during the 4th quarter worth approximately $60,000. Virtu Financial LLC bought a new position in shares of Senseonics during the 4th quarter worth approximately $148,000. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Senseonics by 9.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company's stock worth $1,748,000 after buying an additional 274,842 shares in the last quarter. Institutional investors own 12.36% of the company's stock.

Wall Street Analyst Weigh In

SENS has been the subject of several recent research reports. Mizuho initiated coverage on shares of Senseonics in a research report on Thursday, April 10th. They set an "outperform" rating and a $2.00 target price for the company. HC Wainwright reiterated a "buy" rating and issued a $2.00 target price on shares of Senseonics in a research note on Wednesday, March 5th.

Senseonics Trading Down 0.2 %

Shares of NYSE SENS traded down $0.00 during midday trading on Thursday, reaching $0.74. The company had a trading volume of 1,140,226 shares, compared to its average volume of 6,297,838. Senseonics Holdings, Inc. has a one year low of $0.25 and a one year high of $1.40. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17. The firm's fifty day moving average price is $0.67 and its 200-day moving average price is $0.61. The stock has a market cap of $486.08 million, a PE ratio of -5.72 and a beta of 0.84.

Senseonics (NYSE:SENS - Get Free Report) last released its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same period in the prior year, the firm earned ($0.07) EPS. On average, equities research analysts anticipate that Senseonics Holdings, Inc. will post -0.14 earnings per share for the current year.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.